Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1858 (LINC01858) is a long noncoding RNA (lncRNA) annotated in the human genome. These molecules do not encode proteins but may be involved in the regulation of gene expression through epigenetic and transcriptional mechanisms[1][3]. The specific functions of LINC01858 remain largely uncharacterized in published research. Within the broader lncRNA family, some members have roles in regulating cell proliferation, invasion, and cancer-related pathways, although there is currently limited direct evidence for LINC01858 in these processes[1][5]. LINC01858 is cataloged in major genomic databases (GeneCards, NCBI, Ensembl)[1][3] and is not considered an established drug target, biomarker, or therapeutic intervention point at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1858 (LINC01858).